A phase 2 study of VAS-101 in patients with osteoarthritis
Latest Information Update: 20 Mar 2025
At a glance
- Drugs Curcumin (Primary)
- Indications Pain
- Focus Therapeutic Use
- 20 Mar 2025 New trial record
- 19 Mar 2025 According to a Vascarta media release, pending positive results from phase study trial anticipated to start in 2026.